Oligonucleotide degradation contributes to resistance to antisense compounds

Anticancer Drugs. 1993 Apr;4(2):197-200. doi: 10.1097/00001813-199304000-00011.

Abstract

A subline of the human B cell lymphoma DHL-4, grown in the artificial serum-free medium HB101, displayed a resistant phenotype to the activity of an antisense oligodeoxynucleotide (aODN) effective on the parental DHL-4 line. It was found that the cellular uptake of the 18mer aODN in the two cell lines was almost the same. In contrast, the unresponsive subline DHL-4r degraded the aODN very efficiently, in contrast to the stability of aODN inside cells of the parental DHL-4 line. Activation of the degrading 'machinery' combined with selective properties of the artificial medium may be responsible for the loss of responsiveness to aODN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Base Sequence
  • Drug Resistance
  • Humans
  • Lymphoma, B-Cell
  • Molecular Sequence Data
  • Oligonucleotides / metabolism*
  • Oligonucleotides, Antisense / analysis
  • Oligonucleotides, Antisense / pharmacology*
  • Phosphorus Radioisotopes
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Oligonucleotides
  • Oligonucleotides, Antisense
  • Phosphorus Radioisotopes